CY1115000T1 - HUMAN ANTIBODIES AGAINST RUSSIA AND USE OF THESE - Google Patents

HUMAN ANTIBODIES AGAINST RUSSIA AND USE OF THESE

Info

Publication number
CY1115000T1
CY1115000T1 CY20141100223T CY141100223T CY1115000T1 CY 1115000 T1 CY1115000 T1 CY 1115000T1 CY 20141100223 T CY20141100223 T CY 20141100223T CY 141100223 T CY141100223 T CY 141100223T CY 1115000 T1 CY1115000 T1 CY 1115000T1
Authority
CY
Cyprus
Prior art keywords
russia
human antibodies
antibodies against
antigen
binding fragments
Prior art date
Application number
CY20141100223T
Other languages
Greek (el)
Inventor
William D Thomas Jr
Donna Ambrosino
Robert Mandell
Susan Schonhoff
Gregory J Babcock
Charles Rupprecht
Original Assignee
University Of Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06720126.9A external-priority patent/EP1851315B1/en
Application filed by University Of Massachusetts filed Critical University Of Massachusetts
Publication of CY1115000T1 publication Critical patent/CY1115000T1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Παρέχονται στην παρούσα, ανθρώπινα μονόκλωνα αντισώματα που δεσμεύονται ειδικά στον ιό της λύσσας, τμήματα δέσμευσης αντιγόνου αυτών, και μέθοδοι δημιουργίας και χρήσεως τέτοιων αντισωμάτων και τμημάτων δέσμευσης αντιγόνου αυτών για την θεραπεία του ιού της λύσσας σε ένα υποκείμενο.Presented herein are human monoclonal antibodies that specifically bind to rabies virus, antigen-binding fragments thereof, and methods of generating and using such antibodies and antigen-binding fragments thereof for the treatment of rabies virus in a subject.

CY20141100223T 2005-02-02 2014-03-24 HUMAN ANTIBODIES AGAINST RUSSIA AND USE OF THESE CY1115000T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64951205A 2005-02-02 2005-02-02
EP06720126.9A EP1851315B1 (en) 2005-02-02 2006-02-02 Human antibodies against rabies and uses thereof

Publications (1)

Publication Number Publication Date
CY1115000T1 true CY1115000T1 (en) 2016-12-14

Family

ID=58464024

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100223T CY1115000T1 (en) 2005-02-02 2014-03-24 HUMAN ANTIBODIES AGAINST RUSSIA AND USE OF THESE

Country Status (1)

Country Link
CY (1) CY1115000T1 (en)

Similar Documents

Publication Publication Date Title
CY1121672T1 (en) ANTIBODIES THAT BIND IL-17A AND IL-17F
CY1122458T1 (en) ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
CY1119445T1 (en) ANTIBODIES AGAINST HUMAN GDF8
HK1109636A1 (en) Human antibodies and proteins
CY1117859T1 (en) ANTI-CD79B ANTIBODIES AND IMMUNIZATIONS AND METHODS OF USE
CR10068A (en) ANTI MN ANTIBODIES AND METHODS FOR USE
CY1115700T1 (en) ANTI-CD79B ANTIBODIES AND IMMUNIZATIONS AND METHODS OF USE
CY1115932T1 (en) ANTIBODY PACKAGING
CY1115871T1 (en) METHODS FOR TREATMENT OF URINARY ARTHRITIS
EA200900040A1 (en) ANTIBODY MOLECULES THAT ASSOCIATE WITH HUMAN IL-17
CU20170169A7 (en) FACTOR ANTIBODIES XI
CY1113640T1 (en) METHODS FOR TREATMENT OF Rheumatoid Arthritis
EA201100923A1 (en) HUMAN ANTIBODIES AGAINST THE TISSUE FACTOR
DK1951759T3 (en) Anti-EGFR antibodies
CY1112277T1 (en) HUMANIZED ANTI-β7 COMPETITORS AND THEIR USES
MD3463435T2 (en) Antibodies to alpha-synuclein and uses thereof
AR057807A1 (en) ANTI-CD3 ANTIBODY FORMULATIONS
EA201171060A1 (en) MOLECULES OF ANTIBODIES WITH PECULIARITY OF THE HUMAN OH40
EA201100694A1 (en) ANTIBODY TO CD38 PERSON AND ITS APPLICATION
DK1572087T3 (en) Antibodies with cancer antigen TMEFF2 and applications thereof
EA201070888A1 (en) ANTIBODIES AND THEIR DERIVATIVES
MX2010006767A (en) Hepatitis c virus antibodies.
EA200802182A1 (en) MODIFIED HUMANIZED ANTIBODIES AGAINST INTERLEUKIN-18
EA201070695A1 (en) MOLECULES OF HUMANIZED ANTIBODIES SPECIFIC TO IL-31
ES2639026T3 (en) Totally human antibodies specific for CADM1